FDA Drug Application (022020) for PROTONIX by WYETH PHARMS INC

Back to FDA Applications sponsored by WYETH PHARMS INC

Application Number022020
Product Number001
FormFOR SUSPENSION, DELAYED RELEASE;ORAL
DosageEQ 40MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePROTONIX
Active IngredientPANTOPRAZOLE SODIUM



Back to FDA Applications sponsored by WYETH PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.